* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Different Mechanisms for Turning On Viral Protein Production in
Genome (book) wikipedia , lookup
Genetic engineering wikipedia , lookup
Gene expression profiling wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Gene therapy wikipedia , lookup
Nutriepigenomics wikipedia , lookup
History of genetic engineering wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Gene nomenclature wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Protein moonlighting wikipedia , lookup
Designer baby wikipedia , lookup
DNA vaccination wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Point mutation wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Different Mechanisms for Turning On Viral Protein Production in Human Cells. Ben Adams Viruses are so simple they cannot be called living organisms. Instead they are referred to as ‘biological entities’, growing only by invading host cells and hijacking their metabolic machinery. The human papillomavirus invades cells in the surface layers of the human body, skin and mucosa, causing their uncontrolled growth. Normally these growths are not harmful (benign) and are referred to as warts. However, some ´high risk` types of human papillomavirus cause harmful (malignant) growth which can lead to cancer. The human papillomavirus consists of DNA surrounded by a protein coat. Two proteins form the coat: L1 and L2. Study of L1 is particularly important as this protein is recognised by the body and this recognition helps the body ´fight back` against the virus. By exposing the body to the L1 protein prior to infection, the body will be better equipped at destroying the virus if viral invasion does occur. In my research I have looked at different ways to produce the L1 protein in human cells grown in the laboratory. Different forms of the L1 gene (encoding the L1 protein) were inserted into circular DNA constructs called ´plasmids`. Human cells were infected with the plasmids to see how much L1 protein each different L1 gene produced, by using the cellular machinery in much the same way as the virus does. To produce L1 protein from the gene, a switch or ‘promoter’ was required in front of the L1 gene in the plasmid to turn on L1 protein production in the human cells. I attempted to construct plasmids containing the L1 gene under control of two different types of switch: one switch was on all the time whilst the other could be turned on or off by adding a drug to the cells. I then investigated how much L1 protein was produced from different forms of the L1 gene. I was unable to successfully construct plasmids containing the L1 genes under the promoter that was permanently on. Although plasmids containing the L1 genes under a drug-responsive promoter were constructed successfully, no L1 protein expression was seen in human cells. This was possibly due to problems getting the plasmids into the cells. Human papillomavirus particles Examensarbete i biologi, 10 p, spring 2002 Department of Medical Biochemistry and Microbiology (IMBIM), Uppsala University Supervisor: Prof. Stefan Schwartz, PhD.